Trials / Completed
CompletedNCT00521378
A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- Diasome Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A study designed to determine the appropriate doses of Oral HDV Insulin at meal times.
Conditions
Timeline
- Start date
- 2007-09-17
- Primary completion
- 2007-10-06
- Completion
- 2007-10-06
- First posted
- 2007-08-27
- Last updated
- 2021-05-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00521378. Inclusion in this directory is not an endorsement.